Description
Recombinant monoclonal antibody to Amyloid beta A4 protein. Manufactured using AbAbТs Recombinant Platform with variable regions (i.e. specificity) from the synthetic antibody LY2062430 (Solanezumab, hu266). This is a reformatted human IgG1 Fc SilentЩ antibody, based on the original human IgG1 format, created for improved compatibility with existing reagents, assays and techniques.
Target
Amyloid beta A4 protein
Target Alias Names
APP, A? peptide, Abeta, A-beta, A?, A?42, amyloid beta peptide, Alzheimer disease amyloid protein, Beta-amyloid precursor protein, Protease nexin-II, humanized m266.2
Isotype/Mimetic
IgG1
Animal-Derived Biomaterials Used
No
Sequence Available
No
Original Discovery Information Provided On Datasheet
Yes
Antibody/Binder Origins
Animal-free discovery, Animal-dependent discovery (in vitro display, OR immunisation pre-2020), In vitro recombinant expression